August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Drew Moghanaki: The Role of Preoperative SBRT for NSCLC
Aug 4, 2025, 06:04

Drew Moghanaki: The Role of Preoperative SBRT for NSCLC

Drew Moghanaki, Chief Medical Officer at Respirati, shared a post on X about recent article Nasser Altorki and colleagues authored:

Nasser Altorki‘s team publishes new data investigating the role of preop SBRT for NSCLC. This time, reporting their institutional data comparing preop SBRT-IO vs Chemo-IO. The results demonstrate a significant association with improved RFS at 2 years with SBRT delivered BEFORE immunotherapy (92% vs 64%, HR = 0.19). Technique = 8 Gy x 3, omiting the LNs.”

Drew Moghanaki

Title: Neoadjuvant Non-Ablative SBRT Plus Immunotherapy Yields Similar Pathologic Response as Chemo-Immunotherapy in Non-Small Cell Lung Cancer

Authors: Dan Jones, Abu Nasar, Jonathan Villena-Vargas, Sebron Harrison, Oliver Chow, Muhammad Ali, Eugene Shostak, Ashish Saxena, Christine Garcia, Giuseppe Giaccone, Nicholas J. Sanfilippo, Silvia Formenti, Benjamin Lee, Jeffrey L. Port, Nasser Altorki

Read Full Article.

Drew Moghanaki: The Role of Preoperative SBRT for NSCLC

More posts featuring Drew Moghanaki on OncoDaily.